3-136340619-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005862.3(STAG1):c.3558-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00177 in 1,556,720 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 46 hom. )
Consequence
STAG1
NM_005862.3 intron
NM_005862.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.163
Genes affected
STAG1 (HGNC:11354): (STAG1 cohesin complex component) This gene is a member of the SCC3 family and is expressed in the nucleus. It encodes a component of cohesin, a multisubunit protein complex that provides sister chromatid cohesion along the length of a chromosome from DNA replication through prophase and prometaphase, after which it is dissociated in preparation for segregation during anaphase. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 3-136340619-G-A is Benign according to our data. Variant chr3-136340619-G-A is described in ClinVar as [Benign]. Clinvar id is 1971461.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00332 (505/152240) while in subpopulation EAS AF = 0.0463 (240/5180). AF 95% confidence interval is 0.0415. There are 7 homozygotes in GnomAd4. There are 262 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 505 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00328 AC: 499AN: 152122Hom.: 7 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
499
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00436 AC: 1095AN: 250996 AF XY: 0.00367 show subpopulations
GnomAD2 exomes
AF:
AC:
1095
AN:
250996
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00160 AC: 2249AN: 1404480Hom.: 46 Cov.: 23 AF XY: 0.00153 AC XY: 1072AN XY: 702538 show subpopulations
GnomAD4 exome
AF:
AC:
2249
AN:
1404480
Hom.:
Cov.:
23
AF XY:
AC XY:
1072
AN XY:
702538
Gnomad4 AFR exome
AF:
AC:
254
AN:
32382
Gnomad4 AMR exome
AF:
AC:
30
AN:
44654
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25794
Gnomad4 EAS exome
AF:
AC:
1537
AN:
39412
Gnomad4 SAS exome
AF:
AC:
101
AN:
85056
Gnomad4 FIN exome
AF:
AC:
6
AN:
53376
Gnomad4 NFE exome
AF:
AC:
68
AN:
1059742
Gnomad4 Remaining exome
AF:
AC:
239
AN:
58408
Heterozygous variant carriers
0
106
213
319
426
532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00332 AC: 505AN: 152240Hom.: 7 Cov.: 32 AF XY: 0.00352 AC XY: 262AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
505
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
262
AN XY:
74438
Gnomad4 AFR
AF:
AC:
0.00519756
AN:
0.00519756
Gnomad4 AMR
AF:
AC:
0.00111184
AN:
0.00111184
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.046332
AN:
0.046332
Gnomad4 SAS
AF:
AC:
0.00228595
AN:
0.00228595
Gnomad4 FIN
AF:
AC:
0.0000942685
AN:
0.0000942685
Gnomad4 NFE
AF:
AC:
0.0000588166
AN:
0.0000588166
Gnomad4 OTH
AF:
AC:
0.00757576
AN:
0.00757576
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
121
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at